- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT03546322
Customized Registry Tool for Tracking Adherence to Clinical Guidelines for Head and Neck Cancers
Visão geral do estudo
Descrição detalhada
The investigators aim to implement and evaluate a health information technology (HIT) registry at an urban, public delivery system. The investigators will not assign specific interventions to the study participants, but rather observationally assess the effect of the HIT registry, designed to support routine medical care, on participants.
The investigators will use systems engineering methodologies to design, develop, and implement the platform. The platform will be implemented in the Otolaryngology - Head and Neck Surgery clinic that cares for patients with head and neck cancers. The study will assess patient outcomes and evaluate the time it takes for patients to progress through key treatment and post-treatment milestones before and after the HIT tool is implemented. The investigators will use models controlling for secular trend to estimate the effect of the tool on improving timely and successful completion of guideline-based care processes.
The HIT platform seeks to improve the monitoring and alerting functionality of existing systems. Specifically, it replaces paper-based systems previously used by the clinic to monitor its head and neck cancer patients. It will be implemented clinic-wide for all patients being treated for head and neck cancers. The investigators are not assigning a specific intervention to patients, but rather supporting the clinic and health system in the development of a population management platform that improves routine care processes. The platform is approved for clinical use and research by the San Francisco Health Network and the University of California, San Francisco.
The HIT platform users are clinicians who are responsible for monitoring patients with head and neck cancer and agree to partner with the investigators to improve monitoring processes. The clinicians involved may be asked to voluntarily participate in surveys, interviews, focus groups, and program evaluations. Patient medical records will be reviewed, but patients monitored on the registry will not be contacted by researchers.
Procedures are in place to monitor the registry. First, quality assurance is performed by the research team, information technology analysts, and software engineers. This includes checking that data in the platform matches source data, such as data entered in the electronic health record. In addition, the platform users are audited on a weekly basis. A data dictionary defining variables used in the platform exists and is updated as needed. Patients will be added to the registry by a clinician if they are diagnosed with head and neck cancer. The research team will support the clinicians in data analysis, although this will be performed with population-level, de-identified data. However, if unmediated adverse events are identified by the research team, the research team will alert the clinicians immediately. The HIT platform is designed to supplement, but not replace, the existing electronic health record. Data on the registry will be validated with source data and users will still engage with the source data and electronic health record as appropriate clinically and operationally.
Tipo de estudo
Inscrição (Real)
Contactos e Locais
Locais de estudo
-
-
California
-
San Francisco, California, Estados Unidos, 94110
- Zuckerberg San Francisco General Hospital and Trauma Center
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
Descrição
Inclusion Criteria:
- Patients with head and neck surgery monitored by the Otolaryngology - Head and Neck Surgery Clinic
Exclusion Criteria:
- N/A
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
Coortes e Intervenções
Grupo / Coorte |
Intervenção / Tratamento |
---|---|
Registry
Head and neck cancer patients monitored on registry
|
Patients who are diagnosed with head and neck cancer and monitored by the Otolaryngology - Head and Neck Surgery clinic at Zuckerberg San Francisco General Hospital and Trauma Center will be included in this group.
The intervention is the implementation of a registry, designed to replace existing paper-based systems for tracking patients.
All head and neck cancer patients monitored by the clinic will be included.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Workup and Treatment Planning - Primary Outcome
Prazo: From date of diagnosis to first date of treatment, assessed up to 5 years
|
Time from diagnosis to initiation of treatment
|
From date of diagnosis to first date of treatment, assessed up to 5 years
|
Treatment - Primary Outcome
Prazo: 5 years
|
Proportion of patients that complete tumor board treatment recommendations
|
5 years
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Workup and Treatment Planning - Secondary Outcome #1
Prazo: From date of diagnosis to presentation at tumor board, assessed up to 5 years
|
Time from diagnosis to presentation at tumor board
|
From date of diagnosis to presentation at tumor board, assessed up to 5 years
|
Workup and Treatment Planning - Secondary Outcome #2
Prazo: From date of diagnosis to date of dental evaluation for patients undergoing radiation treatment, assessed up to 5 years
|
Time from diagnosis to dental evaluation
|
From date of diagnosis to date of dental evaluation for patients undergoing radiation treatment, assessed up to 5 years
|
Workup and Treatment Planning - Secondary Outcome #3
Prazo: From date of diagnosis to date of first visit with oncology clinic, assessed up to 5 years
|
Time from diagnosis to first visit in oncology clinics
|
From date of diagnosis to date of first visit with oncology clinic, assessed up to 5 years
|
Treatment - Secondary Outcome
Prazo: 6 weeks
|
Proportion of patients who complete post-treatment radiation
|
6 weeks
|
Loss to follow-up
Prazo: 5 years
|
Proportion of patients who are lost to follow-up
|
5 years
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Urmimala Sarkar, MD, MPH, University of California, San Francisco
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- P30HS023558-1
- P30HS023558 (Concessão/Contrato do NIH dos EUA)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Registry
-
University Hospital, Basel, SwitzerlandConcluído
-
Mayo ClinicConcluído
-
InterMuneConcluídoOsteopetroseEstados Unidos
-
Kaohsiung Medical University Chung-Ho Memorial...ConcluídoCarcinoma hepatocelular | Metástase | InvasãoTaiwan